Skip to Content
Søk Menu
Neurologi
Välkommen till Neurologi

Få höjdpunkter och de senaste nyheterna från neurologi

Seneste nyt fra neurologi

AD/PD 2026 Highlights Nordic Webinar  

  • / BestPractice Nordic

Neurology

  • Meet the Experts
  • 2025
Få tillgang

Patient monitoring and decision-making in CIDP

/ Lars Kjøbsted Markvardsen / Jan Andreasen
CIDP

Evaluating Treatment Response in CIDP: Clinical Precision in a Heterogeneous Disorder

/ Neurologi / Aki Hietaharju / Jan Andreasen

Towards Personalized MS Therapy: microRNAs as Early Indicators of Cladribine Response

/ Neurologi / Jan Andreasen

Possible Biomarkers for Progression Independent of Relapse Activity Identified in RMS

/ Neurologi / Jan Andreasen

Cladribine Shows a Robust Safety Profile – Both as First-Line and Subsequent Therapy in MS

/ Neurologi / Jan Andreasen
Se oversigt

ECTRIMS | Kongres

Vi publicerar de viktigaste höjdpunkterna från ECTRIMS i form av sammanfattningar, onlineartiklar och MEDtalks med internationella och nationella nyckelopinionsledare.

Se allt innehåll

Följ med i nyheter från kongresser 2025/2026

Alzheimers

EAN 2025: Transforming the Diagnostic Pathway in the Era of Disease-Modifying Therapies for Alzheimer’s Disease

/ Neurologi / Kristian Steen Frederiksen

Positive Clinical Effects in the Early Stages of Alzheimer’s Disease: A Focus on Disease-Modifying Therapies

/ Neurologi / BestPractice Nordic

The Risk of Alzheimer's Disease Can Develop Over 10-20 Years Before the Cognitive Symptoms Appear

/ Neurologi / Anne Koivisto

New Biomarkers Will Revolutionize Clinical Practice for Early Onset Alzheimer's and Dementia

/ Neurologi / Eino Solje

Mechanistic Exploration and the Development of New Biomarkers for Alzheimer’s Disease – Focusing on the Brain ‘Garbage’ Clearance System

/ Neurologi / Janet Jianying Zhang / He-Ling Wang / Anne-Brita Knapskog / Geir Selbæk / Evandro Fei Fang
Se oversigt

Myasthenia Gravis

EAN 2025: A Fundamental Shift in Myasthenia Gravis Treatment on the Horizon

/ Neurologi / Nils Erik Gilhus

EAN 2025: Early Add-On Therapy Shows Benefit in Myasthenia Gravis

/ Neurologi / Menekse Oeztuerk

Promising Advances in Myasthenia Gravis Treatment and Pregnancy Outcomes – Insights from Nordic Evening at EAN 2024

/ Neurologi / BestPractice Nordic

Prognostic Factors for Myasthenia Gravis

/ Neurologi / Sini Laakso

EAN 2024: Highlights Regarding Myasthenia Gravis

/ Neurologi / Nils Erik Gilhus
Se oversigt
Tiina Komulainen

Five-Year Prognosis After TIA and TGA Shows Differences in Cardiovascular Risk

/ Tiina Komulainen
Play the Video
Gavin Giovannoni

Multiple Sclerosis as a Continuously Progressive Disease

/ Gavin Giovannoni
MS Play the Video
Shanga Hassan Qadir

Cladribine Effectiveness After Switching from DMTs - A Nationwide Danish Study

/ Shanga Hassan Qadir
ECTRIMS25 Play the Video
Gloria Dalla Costa

ECTRIMS 2025: Ultra-Processed Food Intake is Linked to Increased MS Disease Activity

/ Gloria Dalla Costa
ECTRIMS25 Play the Video
Linda Forsberg

ECTRIMS 2025: Swedish Real-World MS Data Demonstrates Long-Term Safety and Effectiveness of Cladribine

/ Linda Forsberg
ECTRIMS25MS Play the Video
Faisal Mohammad Amin

EAN 2025: New Insights into Headache Disorders – From Prognosis to Potential Biomarkers

/ Faisal Mohammad Amin
EAN25Migrän Play the Video
Load more
Back to top